Perspective Therapeutics
CATX
31 hedge funds and large institutions have $1.66M invested in Perspective Therapeutics in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
7% more capital invested
Capital invested by funds: $1.56M → $1.66M (+$108K)
7% more funds holding
Funds holding: 29 → 31 (+2)
0.01% more ownership
Funds ownership: 0.71% → 0.72% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$86.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$18.5K |
| 3 |
SIA
Starfire Investment Advisers
Southfield,
Michigan
|
+$9.39K |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$7.03K |
| 5 |
Bank of New York Mellon
New York
|
+$5.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$23K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$22.1K |
| 3 |
VF
Virtu Financial
New York
|
-$22K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.08K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IA
26
IFP Advisors
Tampa,
Florida
| $2K | – | – | – |
|
|
JFA
27
JNBA Financial Advisors
Bloomington,
Minnesota
| $2K | – | – | – |
|
28
Morgan Stanley
New York
| $1K | +$207 | +47 | +47% |
|
|
LTFS
29
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$662 | +150 | New |
|
|
AIA
30
Arcadia Investment Advisors
Eagle,
Idaho
| $93 | – | – | – |
|
|
TSS
31
Two Sigma Securities
New York
| – | -$23K | -5,747 | Closed |
|
|
VF
32
Virtu Financial
New York
| – | -$22K | -5,491 | Closed |
|
CATX Hedge Fund Activity: Q1 2018 in Review
31 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2018, worth a combined $1.66M — up 6.9% from $1.56M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CATX positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $86.3K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $23K sold.
- 31 institutional investors held Perspective Therapeutics (CATX) as of Q1 2018, up from 29 in Q4 2017.
- Funds reported $1.66M of Perspective Therapeutics stock for Q1 2018, up 6.9% quarter-over-quarter.
- 4 funds opened new Perspective Therapeutics positions in Q1 2018 and 2 closed out, a net change of +2 holders.
- The largest Perspective Therapeutics buyer in Q1 2018 was Susquehanna International Group, an estimated $86.3K added.
- The largest Perspective Therapeutics seller in Q1 2018 was Two Sigma Securities, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2018.